BANTHINE Drug Patent Profile
✉ Email this page to a colleague
When do Banthine patents expire, and what generic alternatives are available?
Banthine is a drug marketed by Shire and is included in one NDA.
The generic ingredient in BANTHINE is methantheline bromide. Additional details are available on the methantheline bromide profile page.
Summary for BANTHINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 37 |
Patent Applications: | 410 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BANTHINE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for BANTHINE
US Patents and Regulatory Information for BANTHINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shire | BANTHINE | methantheline bromide | TABLET;ORAL | 007390-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |